Guardant Health, Inc.

NASDAQ:GH

42.1 (USD) • At close June 2, 2025
Bedrijfsnaam Guardant Health, Inc.
Symbool GH
Munteenheid USD
Prijs 42.1
Beurswaarde 5,215,684,800
Dividendpercentage 0%
52-weken bereik 20.14 - 52.92
Industrie Diagnostics & Research
Sector Healthcare
CEO Dr. Helmy Eltoukhy Ph.D.
Website https://guardanthealth.com

An error occurred while fetching data.

Over Guardant Health, Inc.

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset

Vergelijkbare Aandelen

Amedisys, Inc. logo

Amedisys, Inc.

AMED

94.49 USD

Novavax, Inc. logo

Novavax, Inc.

NVAX

7.07 USD

Arrowhead Pharmaceuticals, Inc. logo

Arrowhead Pharmaceuticals, Inc.

ARWR

16.4 USD

Surgery Partners, Inc. logo

Surgery Partners, Inc.

SGRY

23.39 USD

Cerevel Therapeutics Holdings, Inc. logo

Cerevel Therapeutics Holdings, Inc.

CERE

44.96 USD

LivaNova PLC logo

LivaNova PLC

LIVN

43.41 USD

Natera, Inc. logo

Natera, Inc.

NTRA

160.69 USD

Merit Medical Systems, Inc. logo

Merit Medical Systems, Inc.

MMSI

93.64 USD

iRhythm Technologies, Inc. logo

iRhythm Technologies, Inc.

IRTC

140.65 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)